Editor LSA

Penny Stock's Buzzers - NanoViricides Inc(OTCMKTS:NNVCD), Medical Marijuana Inc(OTCMKTS:MJNA), Deutsche Telekom AG (ADR)(OTCMKTS:DTEGY), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT)

 

Lewes, DE -- (SBWIRE) -- 09/24/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: NanoViricides Inc(OTCMKTS:NNVCD), Medical Marijuana Inc(OTCMKTS:MJNA), Deutsche Telekom AG (ADR)(OTCMKTS:DTEGY), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT).

NanoViricides Inc(OTCMKTS:NNVCD) ended higher +13.85% and complete the day at $6.00. The total number of shares changed hands during the day was 371,182. After opening at $5.60, the stock hit as high as $6.03. However, it traded between $1.12 and $6.14 over the last twelve months.

NanoViricides, Inc., a nano-biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of viral infections.

For How Long NNVCD will Fight for Profitability? Read This Trend Analysis report

Medical Marijuana Inc(OTCMKTS:MJNA) closed yesterday at $0.152, a -3.01% decrease. Around 8.16 million shares were traded, low from an-average trading volume of 14.76 million shares. The company is now valued at around $143.41 million.

Medical Marijuana, Inc. operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries

Has MJNA Found The Bottom And Ready To Gain Momentum? Find Out Here

Deutsche Telekom AG (ADR)(OTCMKTS:DTEGY) moved +0.43 percent higher at $14.02 and traded between $13.95 and $14.08 after opening the day at $14.05. Its performance over the last five days remained 5.89%, which stands at 7.19% for a month. Going back further than one month, 1-year performance after recent close was 23.39%.

Deutsche Telekom AG operates as an integrated telecommunication company worldwide. The company offers fixed-network services, such as voice and data communication services based on fixed-network and broadband technology; and sells terminal equipment and other hardware, as well as services to resellers.

For How Long DTEGY Gloss will Attract Investors? Find out via this report

Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) shares fall, losing -2.88 percent to close at $1.01. The stock is up around 80.36% this year and 48.97% for the last 12 months. Around 1.05 million shares changed hands yesterday, higher from an-average trading volume of 431,114 shares.

Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company?s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma

Will PVCT Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/